HUP0104420A2 - Therapeutic composition containing a new form of tramadol and its use - Google Patents

Therapeutic composition containing a new form of tramadol and its use

Info

Publication number
HUP0104420A2
HUP0104420A2 HU0104420A HUP0104420A HUP0104420A2 HU P0104420 A2 HUP0104420 A2 HU P0104420A2 HU 0104420 A HU0104420 A HU 0104420A HU P0104420 A HUP0104420 A HU P0104420A HU P0104420 A2 HUP0104420 A2 HU P0104420A2
Authority
HU
Hungary
Prior art keywords
tramadol
composition containing
therapeutic composition
new form
new
Prior art date
Application number
HU0104420A
Other languages
Hungarian (hu)
Inventor
Hazel Bardsley
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9826537.4A external-priority patent/GB9826537D0/en
Priority claimed from GBGB9826536.6A external-priority patent/GB9826536D0/en
Priority claimed from GBGB9826535.8A external-priority patent/GB9826535D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of HUP0104420A2 publication Critical patent/HUP0104420A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
HU0104420A 1998-12-02 1999-12-02 Therapeutic composition containing a new form of tramadol and its use HUP0104420A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9826537.4A GB9826537D0 (en) 1998-12-02 1998-12-02 Therapeutic product and its use
GBGB9826536.6A GB9826536D0 (en) 1998-12-02 1998-12-02 Therapeutic product and its use
GBGB9826535.8A GB9826535D0 (en) 1998-12-02 1998-12-02 Therapeutic product and its use

Publications (1)

Publication Number Publication Date
HUP0104420A2 true HUP0104420A2 (en) 2002-08-28

Family

ID=27269570

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104420A HUP0104420A2 (en) 1998-12-02 1999-12-02 Therapeutic composition containing a new form of tramadol and its use

Country Status (12)

Country Link
EP (1) EP1135361A1 (en)
JP (1) JP2002531431A (en)
KR (1) KR20010080364A (en)
CN (1) CN1329590A (en)
AU (1) AU1400100A (en)
BR (1) BR9915873A (en)
CA (1) CA2350635A1 (en)
HU (1) HUP0104420A2 (en)
IL (1) IL142778A0 (en)
NO (1) NO20012738D0 (en)
PL (1) PL347542A1 (en)
WO (1) WO2000032558A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1164601A (en) * 1999-11-09 2001-06-06 Darwin Discovery Limited Therapeutic use and formulation
KR20030059803A (en) * 2000-10-03 2003-07-10 펜웨스트 파마슈티칼스 컴퍼니 Delivery system for multi-pharmaceutical active materials at various release rates
DE10108122A1 (en) 2001-02-21 2002-10-02 Gruenenthal Gmbh Medicines based on tramadol
WO2003048113A1 (en) 2001-11-30 2003-06-12 Sepracor Inc. Tramadol analogs and uses thereof
JP5269595B2 (en) 2005-09-09 2013-08-21 アンジェリーニ ラボファーム リミテッド ライアビリティ カンパニー Trazodone composition for once daily administration
PL2114147T3 (en) 2007-02-12 2012-10-31 Vyrix Pharmaceuticals Inc Reducing side effects of tramadol
RU2470011C2 (en) * 2007-05-31 2012-12-20 Сепракор Инк. Cycloalkylamines, containing phenyl as substituent, as inhibitors of monoamine reuptake
JOP20190251A1 (en) * 2017-05-31 2019-10-21 Metys Pharmaceuticals AG Synergistic compositions comprising (r)-dimiracetam (1) and (s)-dimiracetam (2) in a non-racemic ratio
KR20200110317A (en) 2017-12-05 2020-09-23 선오비온 파마슈티컬스 인코포레이티드 Crystal form and method for preparing the same
KR20200110648A (en) 2017-12-05 2020-09-24 선오비온 파마슈티컬스 인코포레이티드 Non-racemic mixtures and uses thereof
EP3891150A1 (en) * 2018-12-04 2021-10-13 Metys Pharmaceuticals AG Synergistic compositions comprising-r-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2h)-ones and s-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2h)-ones in a non-racemic ratio
AU2020286441A1 (en) 2019-06-04 2022-01-06 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204116A (en) * 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy
DE69826113T2 (en) * 1997-03-11 2005-01-20 Arakis Ltd., Saffron Walden R AND S-ENANTIOMER SEPARATED DOSAGE FORMS
DE19807535A1 (en) * 1998-02-21 1999-08-26 Asta Medica Ag Drug combination for treating migraine, migraine-type headaches or pain accompanied by nausea, vomiting or delayed gastric emptying

Also Published As

Publication number Publication date
BR9915873A (en) 2001-08-21
IL142778A0 (en) 2002-03-10
CN1329590A (en) 2002-01-02
AU1400100A (en) 2000-06-19
EP1135361A1 (en) 2001-09-26
CA2350635A1 (en) 2000-06-08
WO2000032558A1 (en) 2000-06-08
PL347542A1 (en) 2002-04-08
JP2002531431A (en) 2002-09-24
NO20012738L (en) 2001-06-01
KR20010080364A (en) 2001-08-22
NO20012738D0 (en) 2001-06-01

Similar Documents

Publication Publication Date Title
HUP0101999A3 (en) 4-hydroxyquinoline-3-carboxamides and hydrazides use of them and pharmaceutical compositions containing them
ZA988516B (en) New use for budesonide and formoterol
PL335555A1 (en) Novel compounds - substituted benzamides and therapeutic agent
EP1028735A4 (en) Therapeutic methods comprising use of a neuregulin
HUP0203852A3 (en) A physical form of glyburide and composition containing it
IL116505A0 (en) Compounds with progesterone-antagonistic and antiestrogenic action and the use thereof for the manufacture of pharmaceutical agents
PL347357A1 (en) Novel composition and use
ZA985096B (en) Composition compound and use
GB9717598D0 (en) Novel composition and use
EP1069901A4 (en) Calcilytic compounds and method of use
HUP0104420A2 (en) Therapeutic composition containing a new form of tramadol and its use
IL142385A0 (en) Use of ophthalmic composition comprising vitamin a and vitamin e
IL129662A0 (en) Composition for the treatment of asthma containing loratadine and a decongestant
IL125775A0 (en) Use of a zwitterion composition and a pharmaceutical composition containing the same
ZA959907B (en) Iminooxymethyleneanilides preparation thereof and intermediates therefor and compositions containing them
HUP9701618A3 (en) Pharmaceutical composition containing tramadol and a calcium-canal-antagonist
HUP0103309A3 (en) Novel salts of n-tert-butylhydroxylamine and preparation thereof
GB9718636D0 (en) Novel composition and use
PL337802A1 (en) Preparations containing a low dose of 15-deoxyspergualine
GB9722392D0 (en) Composition and use
HU9700020D0 (en) Composition of material
GB9802622D0 (en) Compounds and their therapeutic use
GB9426449D0 (en) Use of triphenylethylene compounds
GB9704350D0 (en) Compounds and their therapeutic use
GB9719203D0 (en) Novel composition and use